The Legacy Prize recognizes exceptional scientists whose work has the potential to reshape medicine — particularly those who have achieved remarkable results despite limited resources and recognition.
$10K unrestricted funding to advance research without institutional constraints.
12-month advisory connecting laureates with Legacy partners and portfolio leaders.
Strategic guidance on IP, company formation, and bench-to-bedside pathways.
Visibility through Legacy's network of investors, scientists, and industry leaders.
“Every laureate represents a future that almost didn't happen.”— Legacy Venture Capital
Nominations close December 31, 2026.